Please Wait
Applying Filters...
menu
    • menu
    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-08-11

    Virtual Booth

    An Enquiry

    Menu

    Glycerol Excipient

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1BASAGLAR

    02 1HUMULIN R

    03 1HUMULIN R KWIKPEN

    04 1LEVEMIR

    05 1LEVEMIR FLEXPEN

    06 1LEVEMIR FLEXTOUCH

    07 1LEVEMIR INNOLET

    08 1LEVEMIR PENFILL

    09 1NOVOLOG

    10 1NOVOLOG FLEXPEN

    11 1NOVOLOG FLEXTOUCH

    12 1NOVOLOG INNOLET

    13 1NOVOLOG MIX 70/30

    14 1NOVOLOG MIX 70/30 FLEXPEN

    15 1NOVOLOG MIX 70/30 PENFILL

    16 1NOVOLOG PENFILL

    17 1TRESIBA

    18 1XULTOPHY 100/3.6

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers

    01

    NOVO NORDISK INC

    INSULIN DETEMIR RECOMBINANT

    arrow
    ACS Fall 2025
    Not Confirmed
    NOVO NORDISK INC
    Denmark
    arrow
    ACS Fall 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    INSULIN DETEMIR RECOMBINANT

    Drug : LEVEMIR FLEXPEN

    Dosage Form : INJECTABLE; SUBCUTANEOUS

    Application Number : 21536

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    NOVO NORDISK INC

    INSULIN DETEMIR RECOMBINANT

    arrow
    ACS Fall 2025
    Not Confirmed
    NOVO NORDISK INC
    Denmark
    arrow
    ACS Fall 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    INSULIN DETEMIR RECOMBINANT

    Drug : LEVEMIR

    Dosage Form : INJECTABLE; SUBCUTANEOUS

    Application Number : 21536

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    NOVO NORDISK INC
    Denmark
    arrow
    ACS Fall 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT

    Drug : NOVOLOG MIX 70/30 PENFILL

    Dosage Form : INJECTABLE; SUBCUTANEOUS

    Application Number : 21172

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    NOVO NORDISK INC
    Denmark
    arrow
    ACS Fall 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT

    Drug : NOVOLOG MIX 70/30 FLEXPEN

    Dosage Form : INJECTABLE; SUBCUTANEOUS

    Application Number : 21172

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    NOVO NORDISK INC
    Denmark
    arrow
    ACS Fall 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT

    Drug : NOVOLOG MIX 70/30

    Dosage Form : INJECTABLE; SUBCUTANEOUS

    Application Number : 21172

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    NOVO NORDISK INC

    INSULIN ASPART RECOMBINANT

    arrow
    ACS Fall 2025
    Not Confirmed
    NOVO NORDISK INC
    Denmark
    arrow
    ACS Fall 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    INSULIN ASPART RECOMBINANT

    Drug : NOVOLOG FLEXTOUCH

    Dosage Form : INJECTABLE; SUBCUTANEOUS

    Application Number : 20986

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    NOVO NORDISK INC

    INSULIN ASPART RECOMBINANT

    arrow
    ACS Fall 2025
    Not Confirmed
    NOVO NORDISK INC
    Denmark
    arrow
    ACS Fall 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    INSULIN ASPART RECOMBINANT

    Drug : NOVOLOG PENFILL

    Dosage Form : INJECTABLE; SUBCUTANEOUS

    Application Number : 20986

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    NOVO NORDISK INC

    INSULIN ASPART RECOMBINANT

    arrow
    ACS Fall 2025
    Not Confirmed
    NOVO NORDISK INC
    Denmark
    arrow
    ACS Fall 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    INSULIN ASPART RECOMBINANT

    Drug : NOVOLOG INNOLET

    Dosage Form : INJECTABLE; SUBCUTANEOUS

    Application Number : 20986

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    NOVO NORDISK INC

    INSULIN ASPART RECOMBINANT

    arrow
    ACS Fall 2025
    Not Confirmed
    NOVO NORDISK INC
    Denmark
    arrow
    ACS Fall 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    INSULIN ASPART RECOMBINANT

    Drug : NOVOLOG FLEXPEN

    Dosage Form : INJECTABLE; SUBCUTANEOUS

    Application Number : 20986

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    NOVO NORDISK INC

    INSULIN ASPART RECOMBINANT

    arrow
    ACS Fall 2025
    Not Confirmed
    NOVO NORDISK INC
    Denmark
    arrow
    ACS Fall 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    INSULIN ASPART RECOMBINANT

    Drug : NOVOLOG

    Dosage Form : INJECTABLE; SUBCUTANEOUS

    Application Number : 20986

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF